"Promising opportunities will augment our internal pipeline and help Healx to achieve its mission of accelerating novel therapies towards rare disease patients.”
“We’ve been using IN-PART for about a year and the business development activities have been great. In this time, we’ve received industry feedback on our technologies, and started conversations with companies via phone calls and email follow-ups. So far, we’ve been very satisfied and impressed by the results.”